Alto Neuroscience, Inc.

ANRO · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.9B · 68 employees
39
SEC Filings
$20.22
Close 2026-05-28
68
Employees

Business Summary

Part I . Overview We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Through insig hts derived from our scalable and proprietary Precision Psychiatry Platform, or our Platform, we aim to discover brain-based biomarkers to better identify which patients are more likely to respond to our novel product candidates. Our current pipeline consists of seven clinical-stage asset...

Latest Stock Quote

ANRO 2026-05-28 $20.22 O:$20.47 H:$20.48 L:$19.8038 Vol:0.2M VWAP:$20.2032
origin leaf: 39aadd40b3799adfd8d29ed6a9c4fa8324e3e590b8a611ed6d95098d45eaf0a0

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001999480-26-000002EDGAR122K words
2025-03-202024-12-310001999480-25-000025EDGAR—
2024-03-212023-12-310001999480-24-000010EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001999480-25-000090EDGAR25K words
2025-08-132025-06-300001999480-25-000076EDGAR—
2025-05-142025-03-310001999480-25-000037EDGAR—
2024-11-122024-09-300001999480-24-000042EDGAR—
2024-08-132024-06-300001999480-24-000035EDGAR—
2024-05-142024-03-310001999480-24-000022EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001104659-26-038593EDGAR1K words
2026-03-160001104659-26-027953EDGAR—
2026-03-160001999480-26-000001EDGAR—
2025-11-120001999480-25-000089EDGAR—
2025-10-200001104659-25-100801EDGAR—
2025-08-130001999480-25-000075EDGAR—
2025-07-080001999480-25-000061EDGAR—
2025-06-260001999480-25-000053EDGAR—
2025-06-030001999480-25-000048EDGAR—
2025-05-140001999480-25-000035EDGAR—

39 total filings indexed. 20 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001999480
TickerANRO
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.altoneuroscience.com
Listed2024-02-02

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bf8ba6ec94456cc09dd0e6431115523673da5dbd3231c4c44132f3a7872e8499
parent: 40c683a09c9bc056370e817511f454e26c7b9d432c007c86935fbd0eeb619ac5
content hash: df7cbb2be80e5101683cea33b0c691efa89782904c8646a70245cc3d37d9e7f1
signed: 2026-06-02T19:00:12.511Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf